Skip to content
IJCBR|ISSN: 2521-0394
Log in
IJ
IJCBR
Original Research ArticlesPeer-reviewedOpen Access · CC BY 4.0

ASSESSMENT OF SERUM PARAOXONASE-1 ENZYME ACTIVITY, MALONDIALDEHYDE AND VITAMIN-C IN ORAL PREMALIGNANCIES

Kar Param1, Mohod Kanchan2, Puttewar Manish3, Kumar Satish4

  1. 1 Department of Biochemistry, Mahatma Gandhi Institute of Medical Sciences, Sevagram, Maharashtra (corresponding author)
  2. 2 1Department of Biochemistry, Mahatma Gandhi Institute of Medical Sciences, Sevagram, Maharashtra
  3. 3 Department of ENT, Mahatma Gandhi Institute of Medical Sciences, Sevagram, Maharashtra
  4. 4 Department of Biochemistry, Mahatma Gandhi Institute of Medical Sciences, Sevagram, Maharashtra

DOI: 10.31878/ijcbr.2018.43.05 · Published 2018-07-31 · pp. 21-26

Download PDF

Abstract

Background: Oral premalignancies are a group of disease or syndromes which if left untreated can lead to cancer. It carries a great significance in Indian perspective. The actual figure of oral cancers arising from oral premalignancies is not known and to predict accurately the malignant transformations of them is still not possible. Oxidative stress is a known player behind cancerogenesis. Recently decreased Paraoxonase-1 activity and increased oxidative stress markers ware found to be associated with Oral Squamous Cell Carcinoma. So, there is a strong possibility of a similar finding in Oral Premalignancies too. Aim: This study aims to investigate the correlation between serum PON-1 activity and oxidative stress markers (MDA & Vitamin C) in patients with Oral Premalignancies. Material and Methods: A total of 62 patients with clinically diagnosed oral premalignant lesions and diseased controls were chosen for the study. Venous blood samples were collected and PON-1, MDA (in serum) & Vitamin c (in plasma) were analysed spectro-photometrically. Results: significant decreased serum PON-1 activity (P<0.05) and concomitant significantly increased serum MDA (P <0.05) and decreased Vitamin C levels (P<0.05) were observed in premalignancies compared to the controls. These finding were more pronounced in Oral Leukoplakia (OL) than in Oral Submucous Fibrosis (OSMF) with a significant difference. Mean levels of the analysed parameters differed accordingly in the clinical grades of oral premalignancies. Conclusion: It can be envisaged that serum PON-1 activity and increased oxidative stress might be a contributing factor behind pathogenesis and progression of Oral Premalignant Diseases.

References

  1. Carnelio S, Rodrigues GS, Shenoy R, Fernandes D. A Brief Review of Common Oral Premalignant Lesions with Emphasis on Their Management and Cancer Prevention. The Indian Journal of Surgery. 2011;73(4):256-261. [Crossref] [Google Scholar]
  2. Gururaj G, Girish N, Isaac MK. NCMH Background Papers-Burden of disease in India. New Delhi: Ministry of Health & Family Welfare. 2005 [Crossref] [Google Scholar]
  3. Markopoulos AK. Current aspects on oral squamous cell carcinoma. The open dentistry journal. 2012; 6:126. [Crossref] [Google Scholar]
  4. Gupta S, Singh R, Gupta OP, Tripathi A. Prevalence of oral cancer and pre-cancerous lesions and the association with numerous risk factors in North India: A hospital based study. National Journal of Maxillofacial Surgery. 2014;5(2):142-148. [Crossref] [Google Scholar]
  5. Katakwar P, Metgud R, Naik S, Mittal R. Oxidative stress marker in oral cancer: a review. Journal of cancer research and therapeutics. 2016;12(2):438. [Crossref] [Google Scholar]
  6. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol.Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;321(17):1196-7. [Crossref] [Google Scholar]
  7. Aksoy-Sagirli P, Cakmakoglu B, Isbir T, Kaytan-Saglam E, Kizir A, Topuz E, Berkkan H. Paraoxonase-1 192/55 polymorphisms and the risk of lung cancer in a Turkish population. Anticancer research. 2011; 31(6):2225-9. [Crossref] [Google Scholar]
  8. Metin ZB, Aydin S, Unur M, Cakmakoglu B, Toptas B, Hafiz G, &#xC4;&#xB0;sbir T. Oral squamous cell carcinoma and serum paraoxonase 1. The Journal of Laryngology & Otology. 2013; 127(12):1208-13. [Crossref] [Google Scholar]
  9. Gan KN, Smolen AN, Eckerson HW, La Du BN. Purification of human serum paraoxonase/ arylesterase. Evidence for one esterase catalyzing both activities. Drug Metabolism and Disposition. 1991;19(1):100-6 [Crossref] [Google Scholar]
  10. Buege JA, Aust SD. The thiobarbituric acid assay Metods Enzymmol 1978; 52:306-7. [Crossref] [Google Scholar]
  11. Kyaw A. A simple colorimetric method for ascorbic acid determination in blood plasma. Clinica chimica acta. 1978 Jun 1; 86(2):153-7 [Crossref] [Google Scholar]
  12. Ghom AG, Ghom SA. Textbook of oral medicine. JP Medical Ltd; 2014 Sep 30,Chapter 12,Page 221 [Crossref] [Google Scholar]
  13. Warnakulasuriya S, Johnson N, Van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. Journal of oral pathology & medicine. 2007; 36(10):575-80. [Crossref] [Google Scholar]
  14. Yardimci G, Kutlubay Z, Engin B, Tuzun Y. Precancerous lesions of oral mucosa. [Crossref] [Google Scholar]
  15. World Journal of Clinical Cases : WJCC. 2014;2(12):866-872. [Crossref] [Google Scholar]
  16. Murti PR, Bhonsle RB, Pindborg JJ, Daftary DK, Gupta PC, Mehta FS. Malignant transformation rate in oral submucous fibrosis over a 17-year period. Community Dent Oral Epidemiol. 1985;13(6):340-1. [Crossref] [Google Scholar]
  17. Petti S. Pooled estimate of world leukoplakia prevalence: A systemic review. Oral [Crossref] [Google Scholar]
  18. Oncol. 2003;39:770-80 [Crossref] [Google Scholar]
  19. Mehta FS, Gupta PC, Daftary DK, Pindborg JJ, Choksi SK. An epidemiological study of oral cancer and precancerous condition among 101,761 villagers in Maharashtra, India. Int J Cancer. 1972;10:134&#xE2;&#x20AC;&#x201C;41. [Crossref] [Google Scholar]
  20. Pindborg JJ, Chawla TN, Mishra RK, Nagpaul RK, Gupta VK. Frequency of oral carcinoma, leukoplakia, leukokeratosis, leukoedema, sub mucous fibrosis and lichen planus in 10,000 Indians in Lucknow, Uttar Pradesh India; Preliminary Report. J Dent Res. 1965;44:61. [Crossref] [Google Scholar]
  21. Saran S, Agrawal GN. Cancer pattern in central U.P. Indian J Cancer. 1984;21(5):133-6. [Crossref] [Google Scholar]
  22. Mackness B, Hunt R, Durrington PN, Mackness MI. Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein AI in the human artery wall with the progression of atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. d1997; 17(7):1233-8. [Crossref] [Google Scholar]
  23. Mouhamed DH, Ezzaher A, Mechri A, Neffati F, Omezzine A, Bouslama A, Gaha L, Douki W, Najjar MF. Effect of cigarette smoking on paraoxonase 1 activity according to PON1 L55M and PON1 Q192R gene polymorphisms. Environmental health and preventive medicine. 2012; 17(4):316-21 [Crossref] [Google Scholar]
  24. Chole RH, Patil RN, Basak A, Palandurkar K, Bhowate R. Estimation of serum malondialdehyde in oral cancer and precancer and its association with healthy individuals, gender, alcohol, and tobacco abuse. Journal of cancer research and therapeutics. 2010 Oct 1; 6(4):487. [Crossref] [Google Scholar]
  25. Gupta S, Reddy MV, Harinath BC. Role of oxidative stress and antioxidants in aetiopathogenesis and management of oral submucous fibrosis. Indian journal of Clinical biochemistry. 2004 Jan 1; 19(1):138. [Crossref] [Google Scholar]
  26. Metgud R, Bajaj S. Evaluation of salivary and serum lipid peroxidation, and glutathione in oral leukoplakia and oral squamous cell carcinoma. Journal of oral science. 2014; 56(2):135-42. [Crossref] [Google Scholar]
  27. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A. 1989; 86(16):6377-81. [Crossref] [Google Scholar]
  28. Basu S. Antioxidant Changes in Precancerous and Cancerous Lesions of Oral Cavity. [Crossref] [Google Scholar]
  29. International Journal of Life Sciences Research. 2015; 3(1):23-28. [Crossref] [Google Scholar]
  30. Tuovinen V, V&#xC3;&#xA4;&#xC3;&#xA4;n&#xC3;&#xA4;nen M, Kullaa A, Karinp&#xC3;&#xA4;&#xC3;&#xA4; A, Markkanen H, Kumpusalo E. Oral mucosal changes related to plasma ascorbic acid levels. Proc Finn Dent Soc.1992;88(3-4):117-22. [Crossref] [Google Scholar]
  31. Rajendran R. Oral submucous fibrosis: etiology, pathogenesis, and future research. [Crossref] [Google Scholar]
  32. Bulletin of the World Health Organization. 1994;72(6):985. [Crossref] [Google Scholar]